|
2024
|
Invention
|
Modified t cells and uses thereof.
The present invention generally relates to T cells that are m... |
|
|
Invention
|
Lipid nanoparticles and uses thereof. The present disclosure relates generally to lipid nanoparti... |
|
|
Invention
|
Nucleic acids targeting hepatitis b virus (hbv) transcripts and uses thereof. The present disclos... |
|
|
Invention
|
Compositions and methods for immunotherapy - ii. RGS16RGS1RGS2CLUCLU. In some embodiments, there ... |
|
|
Invention
|
Methods for diagnosing and treating ovarian cancer. Disclosed herein is a method of treating canc... |
|
|
Invention
|
A method of treatment. The present disclosure relates generally to methods for the treatment of c... |
|
|
Invention
|
A method of preparing cells for adoptive cell therapy. The present disclosure relates generally t... |
|
2023
|
Invention
|
Fusion proteins and uses thereof. The present disclosure relates generally to fusion proteins com... |
|
|
Invention
|
Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cel... |
|
|
Invention
|
Modified t cells and uses thereof. e.g.e.g.e.g.e.g., a population of modified T cells). In partic... |
|
|
Invention
|
Radiolabelled compounds. Processes for the synthesis of [8944 from [8944]4-salt are provided. The... |
|
|
Invention
|
Nucleic acids and uses thereof. The present disclosure relates generally to (CRISPR) RNA (crRNA) ... |
|
|
Invention
|
Targeted delivery of theranostic agents. The present invention relates to compounds and methods f... |
|
2022
|
Invention
|
Conductometric sensor for detecting a nucleic acid and a method for the detection thereof.
The i... |
|
|
Invention
|
Conductometric sensor for detecting a nucleic acid and a method for the detection thereof. The in... |
|
|
Invention
|
Methods for the analysis of gene expression and uses thereof.
The present disclosure relates gen... |
|
|
Invention
|
Methods for the analysis of gene expression and uses thereof. The present disclosure relates gene... |
|
2021
|
Invention
|
Methods of treating cancer with a combination of tucatinib and an anti-pd-1/anti-pd-l1 antibody. ... |
|
|
Invention
|
Compositions and methods for immunotherapy.
The present disclosure relates generally to T cells,... |
|
|
Invention
|
Compositions and methods for immunotherapy. The present disclosure relates generally to T cells, ... |
|
|
Invention
|
Dual kinase-bromodomain inhibitors.
Provided herein are compounds of Formula (I) that are dual i... |
|
|
Invention
|
Dual kinase-bromodomain inhibitors. Provided herein are compounds of Formula (I) that are dual in... |
|
|
Invention
|
Nitrogen-containing analogs of salinomycin for use in acute myeloid leukemia.
The invention rela... |
|
|
Invention
|
Nitrogen-containing analogs of salinomycin for use in acute myeloid leukemia. The invention relat... |
|
2020
|
Invention
|
Methods of activating cytotoxic leukocytes using ptp1b and ptpn2 inhibitors.
The present inventi... |
|
|
Invention
|
Methods of activating cytotoxic leukocytes using ptp1b and ptpn2 inhibitors. The present inventio... |
|
2019
|
Invention
|
Modified t cells and uses thereof. The present invention generally relates to T cells that are mo... |
|
|
Invention
|
Methods of activating cells via ptp 1b inhibition.
The present invention generally relates to me... |
|
|
Invention
|
Methods of activating cells via ptp 1b inhibition. The present invention generally relates to met... |
|
2017
|
Invention
|
Methods of treating breast cancer and reagents therefor. This disclosure relates to RNA interfere... |
|
|
Invention
|
Methods and products for preventing and/or treating metastatic cancer.
The present invention pro... |
|
|
Invention
|
Chimeric antigen receptor modified t cells. An isolated T cell that is modified to express: a. at... |
|
|
Invention
|
Methods of treating neuroblastoma and reagents therefor.
This disclosure relates to RNA interfer... |
|
|
Invention
|
Methods of treating neuroblastoma and reagents therefor. This disclosure relates to RNA interfere... |
|
|
Invention
|
A method of classification and treatment. The present disclosure relates generally to methods of ... |
|
|
Invention
|
Method of diagnosis. The present invention relates generally to a method of detecting a risk of t... |
|
2016
|
Invention
|
Combination therapy of bromodomain inhibitors and checkpoint blockade.
The present disclosure pr... |
|
|
Invention
|
Combination therapy of bromodomain inhibitors and checkpoint blockade. The present disclosure pro... |
|
|
Invention
|
Method of diagnosis of breast cancer. The present invention relates generally to a method of prog... |
|
|
Invention
|
Breast cancer risk assessment. A method, system and processing system for assessing a risk of an ... |
|
|
Invention
|
Leukaemia stem cell line, its method of production and uses thereof. Bromodomain and extra termin... |
|
2015
|
Invention
|
Biomarker of gastric cancer. The present disclosure relates generally to a biomarker of disease, ... |
|
2014
|
Invention
|
Antibodies against human ryk and uses therefor. The present invention relates to antibodies and a... |
|
2013
|
Invention
|
Methods and products for preventing and/or treating metastatic cancer. The present disclosure rel... |
|
|
Invention
|
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof. 6alkyl.
|
|
2012
|
Invention
|
Radioprotector compounds and methods. The invention relates to novel compounds, processes for the... |
|
2006
|
G/S
|
Scientific, medical and biological research services;
licencing of intellectual property. |
